SchaefferW.I. (1984). Usage of vertebrate, invertebrate and plant cell, tissue and organ culture terminology.In Vitro20, 19–24.
2.
GeyG.O., CoffmanW.D., and KubicekM.T. (1952). Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium.Cancer Research12, 264–265.
3.
SinkovicsJ.G., GyörkeyF., KusykC., and SicilianoM.J. (1978). Growth of human tumor cells in established cultures.Methods in Cancer Research14, 243–323.
4.
SmithH.S., and DollbaumCh.M. (1981). Growth of human tumors in culture.Handbook of Experimental Pharmacology57, 451–490.
5.
FoghJ., DracopoliN., LovelessJ.D., and FoghH. (1982). Cultured human tumor cells for cancer research: assessment of variation and stability of cultural characteristics.Progress in Clinical and Biological Research89, 191–223.
6.
HepburnP.J., and MastersJ.R.W. (1983). The Biological Characteristics of Continuous Cell Lines Derived from Human Bladder. In The Pathology of Bladder Cancer (ed. BryanG.T., CohenS.M.), pp. 213–227. Florida: CRC Press.
7.
EngelL.W., and YoungN.A. (1978). Human breast carcinoma cells in continuous culture: a review.Cancer Research38, 4327–4339.
8.
LeibovitzA., StinsonJ.C., McCombsW.B., McCoyC.E., MazurK.C., and MabryN.D. (1976). Classification of human colorectal adenocarcinoma cell lines.Cancer Research36, 4562–4569.
9.
EastyD.M., EastyG.C., CarterR.L., MonaghanP., and ButlerL.J. (1981). Ten human squamous carcinoma cell lines derived from squamous carcinomas of the head and neck.British Journal of Cancer43, 772–785.
10.
TveitK.M., and PihlA. (1981). Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts.British Journal of Cancer44, 775–786.
11.
BrodeurG.M., GreenA.A., HayesF.A., WilliamsK.J., WilliamsD.L., and TsiatisA.A. (1981). Cytogenetic features of human neuroblastomas and cell lines.Cancer Research41, 4678–4686.
12.
PettengillO.S., SorensonG.D., Wurster-HillD.H., CurpheyT.J., NollW.W., CateC.C., and MaurerL.H. (1980). Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.Cancer45, 906–918.
13.
CarneyD.N., BroderL., EdelsteinM., GazdarA.F., HansenM., HavemannK., MatthewsM.J., SorensonG.D., and VidelovL. (1983). Experimental studies of the biology of human small-cell lung cancer.Cancer Treatment Reports67, 27–35.
14.
AndrewsP.W., BronsonD.L., BenhamF., StricklandS., and KnowlesB.B. (1980). A comparative study of eight cell lines derived from human testicular teratocarcinoma.International Journal of Cancer26, 269–280.
15.
WrightW.C., DanielsW.P., and FoghJ. (1981). Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.Journal of the National Cancer Institute66, 239–247.
16.
GartlerS.M. (1967). Genetic markers as tracers in cell culture.National Cancer Institute Monographs26, 167–195.
17.
O'TooleC.M., PoveyS., HepburnP., and FranksL.M. (1983). Identity of some human bladder cancer cell lines.Nature301, 429–430.
18.
Nelson-ReesW.A., DanielsD.W., and FlandermeyerR.R. (1981). Cross-contamination of cells in culture.Science2T2, 446–452.
FoghJ., WrightW.C., and LovelessJ.D. (1977). Absence of Hela cell contamination in 169 cell lines derived from human tumors.Journal of the National Cancer Institute58, 209–214.
21.
PoveyS., JeremiahS., ArthurE., SteelM., and KleinG. (1980). Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.Annals of Human Genetics44, 119–133.
22.
O'BrienS.J., ShannonJ.E., and GailM.H. (1980). A molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic signatures.In Vitro16, 119–135.
23.
WrightW.C., DanielsW.P., and FoghJ. (1979). Stability of polymorphic enzyme phenotypes in human tumor cell lines.Proceedings of the Society for Experimental Biology and Medicine162, 503–509.
24.
DracopoliN.C., and FoghJ. (1983). Loss of heterozygosity in cultured human tumor cell lines.Journal of the National Cancer Institute70, 83–87.
25.
DracopoliN.C., and FoghJ. (1983). Polymorphic enzyme analysis of cultured human tumor cell lines.Journal of the National Cancer Institute70, 469–476.
26.
GilbertF. (1983). Chromosomes, genes, and cancer: a classification of chromosome abnormalities in cancer.Journal of the National Cancer Institute71, 1107–1114.
27.
WangN., TrendB., BronsonD.L., and FraleyE.E. (1980). Non-random abnormalities in chromosome 1 in human testicular cancers.Cancer Research40, 796–802.
28.
RowleyJ.D. (1984). Biological implications of consistent chromosome rearrangements in leukemia and lymphoma.Cancer Research44, 3159–3168.
29.
HamlynP., and SikoraK. (1983). Oncogenes.Lancetii, 326–330.
30.
WangN., PerkinsK.L., BronsonD.L., and FraleyE.E. (1981). Cytogenetic evidence for premeiotic transformation of human testicular cancers.Cancer Research41, 2135–2140.
31.
NeuwaldP.D., AndersonC., SalivarW.O., AldenderferP.H., DermodyW.C., WeintraubB.D., RosenS.W., Nelson-ReesW.A., and RuddonR.W. (1980). Expression of oncodevelopmental gene products by human tumor cells in culture.Journal of the National Cancer Institute64, 447–459.
32.
ShihC., PadhyL.C., MurrayM., and WeinbergR.A. (1981). Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.Nature290, 261–264.
33.
KimballP.M., and BrattainM.G. (1980). Isolation of a cellular subpopulation from a human colonic carcinoma cell line.Cancer Research40, 1574–1579.
34.
BridgesJ.W. (1980). An Evaluation of the Present Status and Potential Application of In Vitro Toxicity Tests. In Towards Better Safety of Drugs and Pharmaceutical Products (ed. BreimerD.D.), pp. 283–299. North-Holland: Elsevier.
35.
PosteG., and GreigR. (1983). The experimental and clinical implications of cellular heterogeneity in malignant tumors.Journal of Cancer Research and Clinical Oncology106, 159–170.
36.
CilloC., MachJ.-P., SchreyerM., and CarrelS. (1984). Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorimetry analysis.International Journal of Cancer34, 11–20.
37.
MinnaJ.D. (1984). Recent advances of potential clinical importance in the biology of lung cancer.Proceedings of the American Association for Cancer Research25, 393–394.
38.
SpringerE.L. (1980). Comparative study of the cytoplasmic organelles of epithelial cell lines derived from human carcinomas and non-malignant tissues.Cancer Research40, 803–817.
39.
TilgenW., BoukampP., BreitkreutzD., DzarlievaR.T., EngstnerM., HaagD., and FusenigN.E. (1983). Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas.Cancer Research43, 5995–6011.
40.
LeightonJ., AbazaN., TchaoR., GeisingerK., and ValentichJ. (1977). Development of tissue culture procedures for predicting the individual risk of recurrence in bladder cancer.Cancer Research37, 2854–2859.
41.
HajduS.I., BeanM.A., FoghJ., HajduE.O., and RicciA. (1974). Papanicolaou smear of cultured human tumor cells.Acta Cytologica18, 327–332.
42.
FoghJ., FoghJ.M., and OrfeoT. (1977). One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.Journal of the National Cancer Institute59, 221–225.
43.
SharkeyF.E., and FoghJ. (1979). Metastasis of human tumors in athymic nude mice.International Journal of Cancer24, 733–738.
44.
KozlowskiJ.M., FidlerI.J., CampbellD., XuZ.-L., KaighnM.E., and HartI.R. (1984). Metastatic behaviour of human tumor cell lines grown in the nude mouse.Cancer Research44, 3522–3529.
45.
HillB.T. (1983). Use of Continuous Human Tumour Cell Lines to Evaluate Drugs by Clonogenic Assays. In Human Tumour Drug Sensitivity Testing In Vitro, (ed. DendyP.P., HillB.T.), pp. 129–146. London: Academic Press.
46.
FoleyG.E., and EpsteinS.S. (1964). Cell culture and cancer chemotherapy.Advances in Cancer Chemotherapy1, 175–353.
47.
HakalaM.T., and RustumY.M. (1979). The potential value of in vitro screening.Methods in Cancer Research16, 247–287.
48.
HillB.T. (1983). An Overview of Correlations Between Laboratory Tests and Clinical Responses. In Human Tumour Drug Sensitivity Testing In Vitro, (ed. DendyP.P., HillB.T.), pp. 235–249. London: Academic Press.
49.
FinlayG.J., and BaguleyB.C. (1984). The use of human cancer cell lines as a primary screening system for antineoplastic compounds.European Journal of Cancer and Clinical Oncology20, 947–954.
50.
BatemanA.E., SelbyP.J., SteelG.C., and TowseG.D.W. (1980). In vitro chemosensitivity tests on xenografted human melanomas.British Journal of Cancer41, 189–198.
51.
TveitK.M., FodstadO., OlsnesS., and PihlA. (1980). In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.International Journal of Cancer26, 717–722.
52.
TveitK.M., FodstadO., and PihlA. (1981). The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas.International Journal of Cancer28, 403–408.
53.
SalmonS.E. (1983). Clinical Correlation of In Vitro Drug Sensitivity Using the Clonogenic Assay. In Human Tumour Drug Sensitivity Testing In Vitro, (ed. DenbyP.P., HillB.T.), pp. 291–303. London: Academic Press.
54.
CarneyD.N., MitchellJ.B., and KinsellaT.J. (1983). In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants.Cancer Research43, 2086–2811.
55.
OosterhuisJ.W., AndrewsP.W., KnowlesB.B., and DamjanovI. (1984). Effects of cis-platinum on embryonal carcinoma cell lines in vitro.International Journal of Cancer34, 133–139.
56.
ArlettC.F., and HarcourtS.A. (1980). Survey of radiosensitivity in a variety of human cell strains.Cancer Research40, 926–932.
57.
ShoemakerR.H., AbbottB.J., MacdonaldM.M., MayoJ.G., VendittiJ.M., & Wolpert-DeFilippesM.K. (1983). Use of the KB cell line for in vitro cytotoxicity assays.Cancer Treatment Reports67, 97.
58.
TalmadgeJ.E., BenedictK., MadsenJ., and FidlerI.J. (1984). Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases.Cancer Research44, 3801–3805.
59.
SkipperH.E., and SchabelF.M. (1984). Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect.Cancer Treatment Reports68, 43–61.
60.
GoldieJ.H., and ColdmanA.J. (1984). The genetic origin of drug resistance in neoplasms: implications for systemic therapy.Cancer Research44, 3643–3653.
61.
MetelmannH.-R., & Von HoffD.D. (1983). Application of a microsomal drug activation system in a human tumor cloning assay.Investigational New Drugs1, 27–32.
62.
EkwallB. (1983). Screening of toxic compounds in mammalian cell cultures.Annals of the New York Academy of Sciences407, 64–77.
63.
LoquetC., and WiebelF.J. (1982). Geno- and cytotoxicity of nitrosamines, aflatoxin B1, and benzo(a)pyrene in continuous cultures of rat hepatoma cells.Carcinogenesis3, 1213–1218.